159 related articles for article (PubMed ID: 24835144)
21. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
[TBL] [Abstract][Full Text] [Related]
22. Is Season of Diagnosis a Predictor of Cancer Survival? Results from the Zurich Cancer Registry.
Hysaj O; Karavasiloglou N; Limam M; Wanner M; Korol D; Rohrmann S
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296975
[TBL] [Abstract][Full Text] [Related]
23. The Big 3: An Updated Overview of Colorectal, Breast, and Prostate Cancers.
Gordon J; Fischer-Cartlidge E; Barton-Burke M
Nurs Clin North Am; 2017 Mar; 52(1):27-52. PubMed ID: 28189165
[TBL] [Abstract][Full Text] [Related]
24. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
25. Risk of colorectal cancer after the diagnosis of prostate cancer: A population-based study.
Desautels D; Czaykowski P; Nugent Z; Demers AA; Mahmud SM; Singh H
Cancer; 2016 Apr; 122(8):1254-60. PubMed ID: 26919270
[TBL] [Abstract][Full Text] [Related]
26. The relationship between seasonality, latitude and tuberculosis notifications in Pakistan.
Butt MF; Younis S; Wu Z; Hadi SH; Latif A; Martineau AR
BMC Infect Dis; 2021 Feb; 21(1):210. PubMed ID: 33632152
[TBL] [Abstract][Full Text] [Related]
27. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.
Habel LA; Danforth KN; Quesenberry CP; Capra A; Van Den Eeden SK; Weiss NS; Ferrara A
Diabetes Care; 2013 Dec; 36(12):3953-60. PubMed ID: 24170756
[TBL] [Abstract][Full Text] [Related]
28. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
29. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
30. Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer.
Roberts AW; Eiffert S; Wulff-Burchfield EM; Dusetzina SB; Check DK
J Natl Cancer Inst; 2021 Apr; 113(4):425-433. PubMed ID: 32805032
[TBL] [Abstract][Full Text] [Related]
31. Cancer Type and Risk of Newly Diagnosed Depression Among Elderly Medicare Beneficiaries With Incident Breast, Colorectal, and Prostate Cancers.
Alwhaibi M; Sambamoorthi U; Madhavan S; Bias T; Kelly K; Walkup J
J Natl Compr Canc Netw; 2017 Jan; 15(1):46-55. PubMed ID: 28040719
[TBL] [Abstract][Full Text] [Related]
32. The role of vitamin D in cancer prevention.
Garland CF; Garland FC; Gorham ED; Lipkin M; Newmark H; Mohr SB; Holick MF
Am J Public Health; 2006 Feb; 96(2):252-61. PubMed ID: 16380576
[TBL] [Abstract][Full Text] [Related]
33. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
34. Understanding population-based site-specific cancer incidence rates in the USA.
Merrill RM; Sloan A; Novilla LB
J Cancer Educ; 2012 Jun; 27(2):263-8. PubMed ID: 21874603
[TBL] [Abstract][Full Text] [Related]
35. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
[TBL] [Abstract][Full Text] [Related]
36. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
38. Regional and temporal variation in receipt of long-term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United States.
Gibson DC; Raji MA; Baillargeon JG; Kuo YF
Cancer Med; 2021 Mar; 10(5):1550-1561. PubMed ID: 33423372
[TBL] [Abstract][Full Text] [Related]
39. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
40. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
